Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Apr 15, 2026
Sale
Shares
6,374
Price
$6.48
Total Value
$41.30K
Shares Held After
395,517
% of Holdings
1.6%
Apr 15, 2026
Sale
Shares
534
Price
$76.97
Total Value
$41.10K
Shares Held After
51,344
% of Holdings
1.0%
Apr 15, 2026
Sale
Shares
4,466
Price
$76.19
Total Value
$340.26K
Shares Held After
51,878
% of Holdings
7.9%
Apr 15, 2026
Sale
Shares
120,000
Price
$150.09
Total Value
$18.01M
Shares Held After
276,698
% of Holdings
30.2%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Apr 15, 2026
Sale
Shares
326
Price
$25.86
Total Value
$8.43K
Shares Held After
174,209
% of Holdings
0.2%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Apr 15, 2026
Sale
Shares
1,101
Price
$25.24
Total Value
$27.79K
Shares Held After
174,535
% of Holdings
0.6%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Apr 15, 2026
Sale
Shares
2,573
Price
$23.76
Total Value
$61.12K
Shares Held After
175,636
% of Holdings
1.4%

MapLight Therapeutics, Inc. (MPLT)

Lillie James Woodruff — Chief Scientific Officer
Apr 15, 2026
Sale
Shares
1,730
Price
$26.82
Total Value
$46.40K
Shares Held After
297,940
% of Holdings
0.6%

MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol — Chief Discovery Officer
Apr 15, 2026
Sale
Shares
3,316
Price
$26.61
Total Value
$88.24K
Shares Held After
256,612
% of Holdings
1.3%
Apr 15, 2026
Sale
Shares
3,590
Price
$26.61
Total Value
$95.53K
Shares Held After
251,054
% of Holdings
1.4%

MapLight Therapeutics, Inc. (MPLT)

Setia Vishwas — Chief Financial Officer
Apr 15, 2026
Sale
Shares
2,806
Price
$26.87
Total Value
$75.40K
Shares Held After
392,743
% of Holdings
0.7%
Apr 15, 2026
Sale
Shares
1,529
Price
$26.80
Total Value
$40.98K
Shares Held After
190,463
% of Holdings
0.8%

ARDELYX, INC. (ARDX)

RAAB MICHAEL — Director
Apr 15, 2026
Sale
Shares
41,668
Price
$6.29
Total Value
$261.95K
Shares Held After
1,795,614
% of Holdings
2.3%
Apr 15, 2026
Sale
Shares
81,840
Price
$20.27
Total Value
$1.66M
Shares Held After
4,562,546
% of Holdings
1.8%
Apr 15, 2026
Sale
Shares
8,593
Price
$26.90
Total Value
$231.15K
Shares Held After
316,466
% of Holdings
2.6%
Apr 15, 2026
Sale
Shares
9,135
Price
$26.93
Total Value
$246.01K
Shares Held After
1,640,616
% of Holdings
0.6%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL — Chief Financial Officer
Apr 15, 2026
Purchase
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
4,308
% of Holdings
46.1%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Apr 15, 2026
Sale
Shares
100
Price
$130.33
Total Value
$13.03K
Shares Held After
0
% of Holdings
100.0%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Apr 15, 2026
Sale
Shares
639
Price
$129.17
Total Value
$82.54K
Shares Held After
100
% of Holdings
86.5%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Apr 15, 2026
Sale
Shares
561
Price
$128.23
Total Value
$71.94K
Shares Held After
739
% of Holdings
43.2%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Apr 15, 2026
Sale
Shares
1,500
Price
$127.13
Total Value
$190.69K
Shares Held After
1,300
% of Holdings
53.6%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Apr 15, 2026
Sale
Shares
1,502
Price
$125.96
Total Value
$189.20K
Shares Held After
2,800
% of Holdings
34.9%

MapLight Therapeutics, Inc. (MPLT)

Foff Erin Pennock — Chief Medical Officer
Apr 15, 2026
Sale
Shares
2,044
Price
$26.84
Total Value
$54.86K
Shares Held After
401,946
% of Holdings
0.5%
Apr 15, 2026
Sale
Shares
4,500
Price
$23.01
Total Value
$103.53K
Shares Held After
196,141
% of Holdings
2.2%
Apr 15, 2026
Sale
Shares
8,000
Price
$23.01
Total Value
$184.06K
Shares Held After
200,641
% of Holdings
3.8%

Processa Pharmaceuticals, Inc. (PCSA)

Guy Wendy — Chief Administrative Officer
Apr 15, 2026
Purchase
Shares
1,583
Price
$2.97
Total Value
$4.70K
Shares Held After
4,693
% of Holdings
33.7%
Apr 15, 2026
Purchase
Shares
1,545
Price
$2.97
Total Value
$4.59K
Shares Held After
12,107
% of Holdings
12.8%

Processa Pharmaceuticals, Inc. (PCSA)

Lin Patrick — Chief Business - Strategy Off
Apr 15, 2026
Purchase
Shares
1,369
Price
$2.97
Total Value
$4.07K
Shares Held After
4,725
% of Holdings
29.0%
Apr 15, 2026
Purchase
Shares
1,843
Price
$2.97
Total Value
$5.47K
Shares Held After
5,492
% of Holdings
33.6%

Whitehawk Therapeutics, Inc. (WHWK)

Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Apr 15, 2026
Sale
Shares
77,000
Price
$3.86
Total Value
$297.22K
Shares Held After
436,824
% of Holdings
15.0%

Processa Pharmaceuticals, Inc. (PCSA)

Bigora Sian — Chief Development Officer
Apr 15, 2026
Purchase
Shares
1,799
Price
$2.97
Total Value
$5.34K
Shares Held After
5,510
% of Holdings
32.6%
Apr 15, 2026
Purchase
Shares
1,000
Price
$11.70
Total Value
$11.70K
Shares Held After
8,450
% of Holdings
11.8%

Liquidia Corp (LQDA)

JEFFS ROGER — Director
Apr 15, 2026
Sale
Shares
25,000
Price
$40.14
Total Value
$1.00M
Shares Held After
1,466,934
% of Holdings
1.7%

Liquidia Corp (LQDA)

Kaseta Michael — CFO and COO
Apr 15, 2026
Sale
Shares
43,375
Price
$40.14
Total Value
$1.74M
Shares Held After
353,356
% of Holdings
10.9%

Liquidia Corp (LQDA)

Kaseta Michael — CFO and COO
Apr 15, 2026
Sale
Shares
86,971
Price
$40.14
Total Value
$3.49M
Shares Held After
396,731
% of Holdings
18.0%

Liquidia Corp (LQDA)

Kaseta Michael — CFO and COO
Apr 15, 2026
Sale
Shares
9,044
Price
$40.14
Total Value
$363.03K
Shares Held After
396,731
% of Holdings
2.2%
Apr 15, 2026
Sale
Shares
2,000
Price
$96.90
Total Value
$193.80K
Shares Held After
0
% of Holdings
100.0%
Apr 15, 2026
Sale
Shares
799
Price
$58.11
Total Value
$46.43K
Shares Held After
24,040
% of Holdings
3.2%
Apr 15, 2026
Sale
Shares
3,618
Price
$57.21
Total Value
$206.99K
Shares Held After
24,839
% of Holdings
12.7%
Apr 15, 2026
Sale
Shares
2,623
Price
$56.27
Total Value
$147.59K
Shares Held After
28,457
% of Holdings
8.4%
Apr 15, 2026
Sale
Shares
19,060
Price
$14.61
Total Value
$278.47K
Shares Held After
412,498
% of Holdings
4.4%

DEXCOM INC (DXCM)

Brown Michael Jon — EVP, Chief Legal Officer
Apr 15, 2026
Sale
Shares
1,700
Price
$63.04
Total Value
$107.17K
Shares Held After
111,204
% of Holdings
1.5%
Apr 15, 2026
Sale
Shares
235,863
Price
$44.64
Total Value
$10.53M
Shares Held After
3,247,025
% of Holdings
6.8%
Apr 15, 2026
Sale
Shares
235,863
Price
$44.64
Total Value
$10.53M
Shares Held After
3,247,025
% of Holdings
6.8%

GILEAD SCIENCES, INC. (GILD)

Dickinson Andrew D — Chief Financial Officer
Apr 15, 2026
Sale
Shares
3,000
Price
$140.96
Total Value
$422.88K
Shares Held After
176,191
% of Holdings
1.7%

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm & Corp Aff Officer
Apr 15, 2026
Sale
Shares
3,000
Price
$140.96
Total Value
$422.88K
Shares Held After
128,779
% of Holdings
2.3%
Apr 15, 2026
Sale
Shares
385
Price
$90.10
Total Value
$34.69K
Shares Held After
674,956
% of Holdings
0.1%
Apr 15, 2026
Sale
Shares
2,750
Price
$90.10
Total Value
$247.77K
Shares Held After
3,899,917
% of Holdings
0.1%
Apr 15, 2026
Sale
Shares
2,200
Price
$89.95
Total Value
$197.89K
Shares Held After
0
% of Holdings
100.0%

Kymera Therapeutics, Inc. (KYMR)

Chadwick Jeremy G — Chief Operating Officer
Apr 15, 2026
Sale
Shares
1,300
Price
$90.00
Total Value
$117.00K
Shares Held After
61,202
% of Holdings
2.1%
Version: v26.5.2